Orocalm Honing- En Sinaasappelsmaak (Benzydamine Hydrochloride)

Benzydamine hydrochloride, the active ingredient in Orocalm Honing- En Sinaasappelsmaak, is a non‑steroidal anti‑inflammatory drug presented as an oral lozenge for topical oral use. It provides symptomatic relief of sore throat and oral mucosal irritation in adults and children.

GNH USA supplies Orocalm Honing- En Sinaasappelsmaak as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Benzydamine hydrochloride is used for inflammatory conditions of the oral cavity and pharynx. - Sore throat: reduces pain and inflammation in acute pharyngitis. - Oral mucositis: alleviates discomfort associated with chemotherapy‑induced mucosal lesions. - Post‑operative oral discomfort: provides symptomatic relief after dental or oral surgery.

Benzydamine hydrochloride may cause adverse reactions, most of which are mild and localized.

Common Side Effects: - Mild burning sensation: transient feeling of warmth at the site of application. - Taste alteration: temporary metallic or bitter taste. - Mouth dryness: slight reduction in salivation. - Nausea: occasional mild nausea.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe oral ulceration: persistent ulcerative lesions. - Angioedema: rapid swelling of lips or tongue.

Benzydamine hydrochloride should be used with awareness of specific safety considerations. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: limited data; consider risk versus benefit. - Existing oral lesions: avoid if severe ulceration is present. - Concomitant anticoagulants: monitor for increased bleeding in oral tissues. - Age: use with caution in children under 6 years. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Benzydamine hydrochloride can interact with other medicines; some interactions require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticoagulants: may increase risk of oral bleeding. - Other NSAIDs: additive anti‑inflammatory effect may raise gastrointestinal irritation risk.

Moderate Interactions (Monitor Closely): - Alcohol: may enhance local irritation. - Corticosteroid mouth rinses: monitor for altered healing. - Antihistamines: may reduce local anti‑inflammatory effect.